What is Sildenafil?
Sildenafil is a small-molecule phosphodiesterase type 5 inhibitor. Pharmaceutical tablets commonly contain its citrate salt.
Mechanism & research focus
PDE5 inhibition reduces cyclic GMP breakdown and amplifies nitric-oxide-linked smooth-muscle signaling. It does not directly supply nitric oxide.
What the research covers
The official tablet label reports controlled human studies of erectile-function outcomes for the specified pharmaceutical formulation.
What remains uncertain
Clinical evidence for those tablets does not validate the identity, absorption or performance of a research liquid. Effects vary with physiological context, and clinically important contraindications and interactions accompany the drug. Catalog availability is not evidence of pharmaceutical equivalence.
The evidence label describes the linked research, not the suitability of a catalog product for use in people. Formulation, identity, purity, and measured content must be assessed separately.
Sources & studies
Sildenafil tablets: prescribing information ↗
Identity, mechanism and clinical context for the labeled formulation; not validation of a DA catalog product.
Read the full paper for its design, controls and limitations. A source link is not a claim that its tested material matches a DA formulation.
Catalog formats & documentation
Formats grouped by compound identity. Availability and batch documentation remain on Disguised Alpha.
Original DA reference: Sildenafil research guide ↗